T-Rex 2X Inverse MSTR Daily Target ETF vs Synopsys, Inc. — how do they compare? T-Rex 2X Inverse MSTR Daily Target ETF trades at $10.57, while Synopsys, Inc. trades at $390 (market cap $72.47B). The key difference: T-Rex 2X Inverse MSTR Daily Target ETF is trading nearer its 52-week high, Synopsys, Inc. nearer its low. Which is the better fit depends on your goals.
| MSTZ | SNPS | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $27.92 | $645.59 |
52-Week Low | $3.50 | $378.46 |
Market Cap | — | $72.47B |
Enterprise Value | — | $80.82B |
Trailing returns across standard periods
MSTZ is a leveraged ETF that seeks daily investment results corresponding to 200% of the inverse (opposite) of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bearish position on MSTR, a company known for its large Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from its stated daily objective.
Read more on MSTZ →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →